EMA ATMP regulation – Clinical Research Made Simple

EMA’s Oversight of Advanced Therapy Clinical Trials

October 5, 2025

EMA’s Oversight of Advanced Therapy Clinical Trials How EMA Oversees Advanced Therapy Clinical Trials in Europe Advanced Therapy Medicinal Products (ATMPs)—which include gene therapies, cell therapies, and tissue-engineered products—represent some of the most innovative yet complex areas in modern clinical research. In the European Union (EU), ATMP trials are subject to strict regulatory oversight by…

Clinical Trials in EU, Country-Specific Clinical Trials

Advanced Therapy Medicinal Products (ATMPs) Regulation in the EU: An EMA Overview

May 15, 2025

digi

Advanced Therapy Medicinal Products (ATMPs) Regulation in the EU: An EMA Overview Understanding EMA Regulation of Advanced Therapy Medicinal Products (ATMPs) in the EU Advanced Therapy Medicinal Products (ATMPs) represent one of the most innovative and complex frontiers in modern medicine. Comprising gene therapies, somatic cell therapies, and tissue-engineered products, ATMPs hold the potential to…

EMA (European Medicines Agency) Guidelines, Regulatory Guidelines